Open AccessImplications for Systemic Approaches to COVID-19: Effect Sizes of Remdesivir, Tocilizumab, Melatonin, Vitamin D3, and Meditation
Author(s) -
Ryan Castle,
Michelle A. Williams,
William C. Bushell,
J. Adam Rindfleisch,
Christine Tara Peterson,
James Marzolf,
Kimberly C. Brouwer,
Paul J. Mills
Publication year - 2021
Publication title -
journal of inflammation research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.656
H-Index - 33
ISSN - 1178-7031
DOI - 10.2147/jir.s323356
Subject(s) - tocilizumab , medicine , melatonin , psychological intervention , vitamin d and neurology , covid-19 , adjunctive treatment , immunology , disease , infectious disease (medical specialty) , psychiatry
COVID-19 poses a chronic threat to inflammatory systems, reinforcing the need for efficient anti-inflammatory strategies. The purpose of this review and analysis was to determine the efficacy of various interventions upon the inflammatory markers most affected by COVID-19. The focus was on the markers associated with COVID-19, not the etiology of the virus itself.